{"hands_on_practices": [{"introduction": "Understanding the functional consequence of a genetic variant is a cornerstone of genomic diagnostics. This first exercise provides a foundational workout in applying the central dogma to predict how a single nucleotide change in a DNA sequence translates into a potential change in the resulting protein [@problem_id:4389685]. By systematically analyzing substitutions at each position of a codon, you will gain a deeper appreciation for the structure of the genetic code, including concepts like synonymous and non-synonymous mutations, and the generation of stop codons.", "problem": "A clinical laboratory observes recurrent single nucleotide variants (SNVs) affecting a triplet in a cancer-associated locus. To quantify predicted protein-level consequences in a strand-aware, codon-degenerate framework, consider the following scientifically consistent setup based on the Central Dogma of Molecular Biology: deoxyribonucleic acid (DNA) on the coding (sense) strand contains the triplet CAG, which is transcribed to Messenger Ribonucleic Acid (mRNA) as CAG (with thymine replaced by uracil in RNA, but for this exercise use DNA alphabet to keep codon identities comparable), and translated according to the standard nuclear genetic code. Assume a single nucleotide variant is a substitution of exactly one base in the triplet to any of the other three canonical deoxyribonucleotides (adenine, cytosine, guanine, thymine). Variants may be reported on either the coding strand or the template (antisense) strand, but translation is determined by the mRNA derived from the coding strand. Treat translation termination (a stop codon) as a distinct outcome class alongside amino acids. Ignore all context effects beyond the triplet (for example, initiation context, splicing, RNA editing, and post-translational modification), and assume the reading frame is fixed.\n\nStarting from these fundamental principles (codon-to-amino acid mapping under the standard genetic code and Watsonâ€“Crick base pairing), derive the number of distinct translated outcomes reachable by any single-base substitution at the first, second, or third position of the codon CAG. Distinct outcomes are counted by unique amino acid identities or the stop signal, not by unique codons per se. Your final answer should be a row matrix with three entries $n_1$, $n_2$, and $n_3$, where $n_1$ is the number of distinct outcomes for variants at position $1$, $n_2$ for position $2$, and $n_3$ for position $3$ of the codon. Express the final answer as a row matrix and do not include units. No rounding is required.", "solution": "The problem requires the determination of the number of distinct translated outcomes resulting from single nucleotide variants (SNVs) at each of the three positions of the codon `$\\text{CAG}$`. The analysis is based on the principles of the central dogma, including DNA complementarity, transcription, and translation according to the standard nuclear genetic code.\n\nFirst, we establish the initial state. The coding (sense) strand of DNA contains the triplet `5'-CAG-3'`. According to the standard genetic code, this codon is transcribed into the messenger RNA (mRNA) codon `5'-CAG-3'` (using the deoxyribonucleotide `$\\text{T}$` in place of `$\\text{U}$` for thymine and uracil, as permitted by the problem statement). This mRNA codon translates to the amino acid Glutamine, abbreviated as `$\\text{Gln}$` or `$\\text{Q}$`.\n\nThe template (antisense) strand is complementary to the coding strand. Following Watson-Crick base pairing rules (`$\\text{A}$` pairs with `$\\text{T}$`; `$\\text{C}$` pairs with `$\\text{G}$`), the template strand corresponding to `5'-CAG-3'` is `3'-GTC-5'`.\n\nThe problem specifies that variants may be reported on either the coding or the template strand. We must analyze the implications of this. A single nucleotide substitution at a given position in the DNA double helix can be viewed as a change in one of the two bases of a base pair. For example, at position $1$, the base pair is `$\\text{C:G}$` (coding:template). A substitution on the coding strand might be `$\\text{C} \\to \\text{A}$`. This changes the codon to `$\\text{AAG}$`. For this to be a stable change, the corresponding template base must change from `$\\text{G}$` to `$\\text{T}$`. This exact same outcome (`$\\text{AAG}$` codon) is achieved if the mutation is considered to have occurred on the template strand as `$\\text{G} \\to \\text{T}$`. In general, for any base `$\\text{N}$` on the coding strand, the set of three possible substitutions `$\\{\\text{N}_1, \\text{N}_2, \\text{N}_3\\}$` is equivalent to the set of substitutions on the complementary template base `$\\text{N'}$` that result in `$\\{\\text{N}_1, \\text{N}_2, \\text{N}_3\\}$` appearing on the coding strand. Thus, enumerating the three possible substitutions on the coding strand for each position is sufficient to account for all possible single-base substitution outcomes.\n\nLet $n_1$, $n_2$, and $n_3$ be the number of distinct translated outcomes for SNVs at position $1$, $2$, and $3$ of the codon `$\\text{CAG}$`, respectively. A distinct outcome is a unique amino acid or a stop signal.\n\n**Analysis for Position 1 ($n_1$):**\nThe original codon is `$\\text{CAG}$` (`$\\text{Gln}$`). The first base is `$\\text{C}$`. The three possible substitutions are to `$\\text{A}$`, `$\\text{G}$`, or `$\\text{T}$`.\n1.  Substitution `$\\text{C} \\to \\text{A}$`: The resulting codon is `$\\text{AAG}$`. `$\\text{AAG}$` translates to Lysine (`$\\text{Lys}$`).\n2.  Substitution `$\\text{C} \\to \\text{G}$`: The resulting codon is `$\\text{GAG}$`. `$\\text{GAG}$` translates to Glutamic Acid (`$\\text{Glu}$`).\n3.  Substitution `$\\text{C} \\to \\text{T}$`: The resulting codon is `$\\text{TAG}$`. `$\\text{TAG}$` is a stop codon (`$\\text{STOP}$`).\nThe set of distinct translated outcomes is `$\\{\\text{Lys}, \\text{Glu}, \\text{STOP}\\}$`. The number of distinct outcomes is $3$.\nTherefore, $n_1 = 3$.\n\n**Analysis for Position 2 ($n_2$):**\nThe original codon is `$\\text{CAG}$` (`$\\text{Gln}$`). The second base is `$\\text{A}$`. The three possible substitutions are to `$\\text{C}$`, `$\\text{G}$`, or `$\\text{T}$`.\n1.  Substitution `$\\text{A} \\to \\text{C}$`: The resulting codon is `$\\text{CCG}$`. `$\\text{CCG}$` translates to Proline (`$\\text{Pro}$`).\n2.  Substitution `$\\text{A} \\to \\text{G}$`: The resulting codon is `$\\text{CGG}$`. `$\\text{CGG}$` translates to Arginine (`$\\text{Arg}$`).\n3.  Substitution `$\\text{A} \\to \\text{T}$`: The resulting codon is `$\\text{CTG}$`. `$\\text{CTG}$` translates to Leucine (`$\\text{Leu}$`).\nThe set of distinct translated outcomes is `$\\{\\text{Pro}, \\text{Arg}, \\text{Leu}\\}$`. The number of distinct outcomes is $3$.\nTherefore, $n_2 = 3$.\n\n**Analysis for Position 3 ($n_3$):**\nThe original codon is `$\\text{CAG}$` (`$\\text{Gln}$`). The third base is `$\\text{G}$`. The three possible substitutions are to `$\\text{A}$`, `$\\text{C}$`, or `$\\text{T}$`.\n1.  Substitution `$\\text{G} \\to \\text{A}$`: The resulting codon is `$\\text{CAA}$`. `$\\text{CAA}$` translates to Glutamine (`$\\text{Gln}$`), which is a synonymous substitution.\n2.  Substitution `$\\text{G} \\to \\text{C}$`: The resulting codon is `$\\text{CAC}$`. `$\\text{CAC}$` translates to Histidine (`$\\text{His}$`).\n3.  Substitution `$\\text{G} \\to \\text{T}$`: The resulting codon is `$\\text{CAT}$`. `$\\text{CAT}$` also translates to Histidine (`$\\text{His}$`).\nThe set of distinct translated outcomes is `$\\{\\text{Gln}, \\text{His}\\}$`. The number of distinct outcomes is $2$.\nTherefore, $n_3 = 2$.\n\nCombining the results, the number of distinct translated outcomes for single-base substitutions at positions $1$, $2$, and $3$ are $3$, $3$, and $2$, respectively. This is to be expressed as a row matrix $(n_1, n_2, n_3)$.", "answer": "$$\\boxed{\\begin{pmatrix} 3 & 3 & 2 \\end{pmatrix}}$$", "id": "4389685"}, {"introduction": "Gene expression is not just about what protein is made, but how much and when. This practice moves our focus from the coding sequence to the promoter, a key regulatory region that controls transcription initiation [@problem_id:4389738]. You will use a Position Weight Matrix (PWM), a fundamental tool in computational biology, to quantify how a mutation in a TATA-box affects the binding energy of TATA-binding protein and, consequently, the rate of transcription.", "problem": "A variant in a human promoter changes the canonical TATA-box substring from `TATAAA` to `TATGAA`. Transcription initiation by RNA polymerase II depends on the binding of TATA-binding protein (TBP) to the TATA-box, and TBP binding affinity can be modeled using a Position Weight Matrix (PWM). Assume the following for the six-base TATA-box window corresponding to positions $i = 1,2,3,4,5,6$ and bases $b \\in \\{ \\mathrm{A}, \\mathrm{C}, \\mathrm{G}, \\mathrm{T} \\}$:\n\n- Background nucleotide frequencies are uniform, $p_{\\mathrm{bg}}(\\mathrm{A}) = p_{\\mathrm{bg}}(\\mathrm{C}) = p_{\\mathrm{bg}}(\\mathrm{G}) = p_{\\mathrm{bg}}(\\mathrm{T}) = 0.25$.\n- The PWM entries $P(b,i)$ (probability of base $b$ at position $i$ among TBP-bound sites) are:\n  - $i=1$: $P(\\mathrm{A},1)=0.20$, $P(\\mathrm{C},1)=0.05$, $P(\\mathrm{G},1)=0.05$, $P(\\mathrm{T},1)=0.70$.\n  - $i=2$: $P(\\mathrm{A},2)=0.75$, $P(\\mathrm{C},2)=0.05$, $P(\\mathrm{G},2)=0.05$, $P(\\mathrm{T},2)=0.15$.\n  - $i=3$: $P(\\mathrm{A},3)=0.10$, $P(\\mathrm{C},3)=0.05$, $P(\\mathrm{G},3)=0.05$, $P(\\mathrm{T},3)=0.80$.\n  - $i=4$: $P(\\mathrm{A},4)=0.90$, $P(\\mathrm{C},4)=0.02$, $P(\\mathrm{G},4)=0.03$, $P(\\mathrm{T},4)=0.05$.\n  - $i=5$: $P(\\mathrm{A},5)=0.85$, $P(\\mathrm{C},5)=0.05$, $P(\\mathrm{G},5)=0.05$, $P(\\mathrm{T},5)=0.05$.\n  - $i=6$: $P(\\mathrm{A},6)=0.80$, $P(\\mathrm{C},6)=0.05$, $P(\\mathrm{G},6)=0.05$, $P(\\mathrm{T},6)=0.10$.\n\nUse the log-odds binding score $S(\\text{seq}) = \\sum_{i=1}^{6} \\ln\\!\\big( P(b_i,i) / p_{\\mathrm{bg}}(b_i) \\big)$, where $b_i$ is the base at position $i$ in the sequence and $\\ln$ denotes the natural logarithm. Under the equilibrium statistical thermodynamics relation between association constant and free energy, $K_{a} \\propto \\exp(-\\Delta G / (R T))$, differences in TBP binding free energy between two sequences are related to differences in PWM log-odds scores by $\\Delta \\Delta G = - R T \\, \\Delta S$, where $\\Delta S = S(\\text{mut}) - S(\\text{wt})$. Assume a physiological temperature $T = 310$ K and use the molar gas constant $R = 8.314 \\times 10^{-3}$ in units of $\\mathrm{kJ}\\, \\mathrm{mol}^{-1}\\, \\mathrm{K}^{-1}$.\n\nAssume the initiation rate in the low TBP concentration regime is proportional to TBP occupancy, and thus proportional to $K_a$. Compute:\n1. The change in TBP binding free energy $ \\Delta \\Delta G $ in $\\mathrm{kJ/mol}$ for the mutation `TATAAA` $\\to$ `TATGAA`.\n2. The fold-change in initiation rate $ r_{\\mathrm{mut}} / r_{\\mathrm{wt}} $ (dimensionless).\n\nRound your numerical answers to four significant figures. Express the free energy in $\\mathrm{kJ/mol}$ and the fold-change as a decimal number without a percentage sign.", "solution": "The problem requires the calculation of two quantities: the change in binding free energy, $\\Delta \\Delta G$, and the fold-change in initiation rate, $r_{\\mathrm{mut}}/r_{\\mathrm{wt}}$.\n\nFirst, we calculate the change in the log-odds score, $\\Delta S$, between the mutant (`TATGAA`) and wild-type (`TATAAA`) sequences.\nThe score for the wild-type sequence is:\n$$S(\\mathrm{wt}) = \\sum_{i=1}^{6} \\ln\\left( \\frac{P(b_i^{\\mathrm{wt}}, i)}{p_{\\mathrm{bg}}(b_i^{\\mathrm{wt}})} \\right)$$\nThe score for the mutant sequence is:\n$$S(\\mathrm{mut}) = \\sum_{i=1}^{6} \\ln\\left( \\frac{P(b_i^{\\mathrm{mut}}, i)}{p_{\\mathrm{bg}}(b_i^{\\mathrm{mut}})} \\right)$$\nThe change in score is $\\Delta S = S(\\mathrm{mut}) - S(\\mathrm{wt})$. The sequences `TATAAA` and `TATGAA` are identical except at position $i=4$, where the base changes from $\\mathrm{A}$ in the wild-type to $\\mathrm{G}$ in the mutant. Therefore, the terms for $i=1,2,3,5,6$ in the summation cancel out.\n$$\\Delta S = \\left( \\sum_{i=1}^{6} \\ln\\left(\\frac{P(b_i^{\\mathrm{mut}}, i)}{p_{\\mathrm{bg}}(b_i^{\\mathrm{mut}})}\\right) \\right) - \\left( \\sum_{i=1}^{6} \\ln\\left(\\frac{P(b_i^{\\mathrm{wt}}, i)}{p_{\\mathrm{bg}}(b_i^{\\mathrm{wt}})}\\right) \\right)$$\n$$\\Delta S = \\ln\\left(\\frac{P(b_4^{\\mathrm{mut}}, 4)}{p_{\\mathrm{bg}}(b_4^{\\mathrm{mut}})}\\right) - \\ln\\left(\\frac{P(b_4^{\\mathrm{wt}}, 4)}{p_{\\mathrm{bg}}(b_4^{\\mathrm{wt}})}\\right)$$\nSince the background frequencies are uniform ($p_{\\mathrm{bg}}(\\mathrm{A}) = p_{\\mathrm{bg}}(\\mathrm{G}) = 0.25$), this simplifies further:\n$$\\Delta S = \\ln\\left(\\frac{P(\\mathrm{G}, 4)}{0.25}\\right) - \\ln\\left(\\frac{P(\\mathrm{A}, 4)}{0.25}\\right) = \\ln\\left( \\frac{P(\\mathrm{G}, 4)/0.25}{P(\\mathrm{A}, 4)/0.25} \\right) = \\ln\\left( \\frac{P(\\mathrm{G}, 4)}{P(\\mathrm{A}, 4)} \\right)$$\nUsing the provided PWM values for position $i=4$: $P(\\mathrm{A},4) = 0.90$ and $P(\\mathrm{G},4) = 0.03$.\n$$\\Delta S = \\ln\\left( \\frac{0.03}{0.90} \\right) = \\ln\\left( \\frac{1}{30} \\right) = -\\ln(30)$$\n\nNow we can calculate the change in TBP binding free energy, $\\Delta \\Delta G$.\n$$\\Delta \\Delta G = - R T \\, \\Delta S$$\nSubstituting the expression for $\\Delta S$:\n$$\\Delta \\Delta G = - R T (-\\ln(30)) = R T \\ln(30)$$\nUsing the given values $R = 8.314 \\times 10^{-3} \\, \\mathrm{kJ}\\, \\mathrm{mol}^{-1}\\, \\mathrm{K}^{-1}$ and $T = 310 \\, \\mathrm{K}$:\n$$\\Delta \\Delta G = (8.314 \\times 10^{-3} \\, \\mathrm{kJ}\\, \\mathrm{mol}^{-1}\\, \\mathrm{K}^{-1}) \\times (310 \\, \\mathrm{K}) \\times \\ln(30)$$\n$$\\Delta \\Delta G \\approx (2.57734 \\, \\mathrm{kJ/mol}) \\times (3.401197)$$\n$$\\Delta \\Delta G \\approx 8.76633 \\, \\mathrm{kJ/mol}$$\nRounding to four significant figures, the change in free energy is $8.766 \\, \\mathrm{kJ/mol}$. The positive value indicates that binding is energetically less favorable for the mutant sequence, as expected for a mutation from a highly conserved base to a rare one.\n\nNext, we calculate the fold-change in the initiation rate, $r_{\\mathrm{mut}} / r_{\\mathrm{wt}}$.\nThe problem states that the rate $r$ is proportional to the association constant $K_a$, so $r_{\\mathrm{mut}}/r_{\\mathrm{wt}} = K_{a, \\mathrm{mut}}/K_{a, \\mathrm{wt}}$.\nThe association constant is related to the Gibbs free energy of binding $\\Delta G$ by $K_a \\propto \\exp(-\\Delta G / (RT))$.\nThe ratio of association constants is therefore:\n$$\\frac{K_{a, \\mathrm{mut}}}{K_{a, \\mathrm{wt}}} = \\frac{\\exp(-\\Delta G_{\\mathrm{mut}} / (RT))}{\\exp(-\\Delta G_{\\mathrm{wt}} / (RT))} = \\exp\\left(-\\frac{\\Delta G_{\\mathrm{mut}} - \\Delta G_{\\mathrm{wt}}}{RT}\\right) = \\exp\\left(-\\frac{\\Delta \\Delta G}{RT}\\right)$$\nWe have the relation $\\Delta \\Delta G = -RT \\Delta S$. Substituting this into the expression for the fold-change:\n$$\\frac{r_{\\mathrm{mut}}}{r_{\\mathrm{wt}}} = \\exp\\left(-\\frac{-RT \\Delta S}{RT}\\right) = \\exp(\\Delta S)$$\nWe previously found that $\\Delta S = \\ln(1/30)$.\n$$\\frac{r_{\\mathrm{mut}}}{r_{\\mathrm{wt}}} = \\exp\\left(\\ln\\left(\\frac{1}{30}\\right)\\right) = \\frac{1}{30}$$\nAs a decimal, this is approximately $0.033333...$.\nRounding to four significant figures, the fold-change in initiation rate is $0.03333$. This indicates a substantial decrease in the transcription initiation rate due to the mutation, which is consistent with the calculated increase in binding free energy.\n\nSummary of results:\n1.  $\\Delta \\Delta G \\approx 8.766 \\, \\mathrm{kJ/mol}$\n2.  $r_{\\mathrm{mut}} / r_{\\mathrm{wt}} \\approx 0.03333$", "answer": "$$\\boxed{\\begin{pmatrix} 8.766 & 0.03333 \\end{pmatrix}}$$", "id": "4389738"}, {"introduction": "Regulation of the central dogma extends beyond transcription, with post-transcriptional mechanisms providing another layer of fine-tuned control. This exercise delves into the world of microRNAs (miRNAs), small non-coding RNAs that can modulate mRNA stability and translation [@problem_id:4389740]. By applying a kinetic birth-death model, you will calculate the impact of miRNA-mediated decay on the steady-state abundance of a target mRNA, bridging the gap between molecular interactions and systems-level outcomes.", "problem": "A reporter messenger ribonucleic acid (mRNA) in a human cell line is transcribed at a constant rate and degraded through first-order kinetics. According to the Central Dogma of Molecular Biology, transcription produces mRNA and mRNA is removed by decay. In a birth-death framework, the production (birth) is at a constant transcription rate and the loss (death) is proportional to the current mRNA abundance. Introducing a target site for microRNA-21 (miR-21) into the reporter 3' untranslated region is known to recruit the RNA-induced silencing complex (RISC), thereby augmenting the mRNA decay rate when the site is occupied by miR-21.\n\nAssume the following physically realistic conditions:\n- The transcription rate is constant at $k_{s} = 8.4$ molecules$\\cdot\\mathrm{min}^{-1}\\cdot\\mathrm{cell}^{-1}$.\n- The basal (miRNA-independent) first-order decay rate constant is $d_{0} = 0.042\\,\\mathrm{min}^{-1}$.\n- The introduction of a single miR-21 site augments the decay rate by an additive term $a\\,p$, where $a$ is an efficiency constant with units of $\\mathrm{min}^{-1}$ and $p$ is the equilibrium occupancy probability of the site by miR-21.\n- The occupancy probability $p$ is determined by mass-action equilibrium with a single binding site: $p = \\dfrac{[\\mathrm{miR\\text{-}21}]}{K_{d} + [\\mathrm{miR\\text{-}21}]}$, where $[\\mathrm{miR\\text{-}21}] = 13\\,\\mathrm{nM}$ is the cytosolic miR-21 concentration and $K_{d} = 7\\,\\mathrm{nM}$ is the dissociation constant of the site.\n- The miRNA-mediated efficiency constant is $a = 0.055\\,\\mathrm{min}^{-1}$.\n- Ignore any translational repression; miR-21 affects only the decay rate.\n\nStarting from the birth-death description of mRNA dynamics and the equilibrium occupancy, derive the steady-state mRNA abundance with the miR-21 site, and then compute its numerical value using the parameters above. Round your final numerical answer to four significant figures. Express the final mRNA abundance in molecules per cell.", "solution": "Let $m(t)$ be the number of mRNA molecules per cell at time $t$. The dynamics of the mRNA abundance are described by a first-order ordinary differential equation (ODE) representing a birth-death process:\n$$ \\frac{dm(t)}{dt} = \\text{Rate of Production} - \\text{Rate of Degradation} $$\nThe production rate is the constant transcription rate, $k_s$.\n$$ \\text{Rate of Production} = k_s $$\nThe degradation is a first-order process, meaning its rate is proportional to the current mRNA abundance $m(t)$. The overall first-order decay rate constant, $d_{total}$, is the sum of the basal decay rate constant, $d_0$, and the miRNA-mediated augmentation, $a\\,p$.\n$$ d_{total} = d_0 + a\\,p $$\nThus, the rate of degradation is:\n$$ \\text{Rate of Degradation} = d_{total} \\cdot m(t) = (d_0 + a\\,p) m(t) $$\nCombining these terms, the full ODE for mRNA abundance is:\n$$ \\frac{dm(t)}{dt} = k_s - (d_0 + a\\,p) m(t) $$\nAt steady-state, the abundance of mRNA is constant, which means its time derivative is zero. Let $m_{ss}$ denote the steady-state mRNA abundance.\n$$ \\frac{dm(t)}{dt} \\Big|_{t \\to \\infty} = 0 $$\nSetting the ODE to zero gives:\n$$ 0 = k_s - (d_0 + a\\,p) m_{ss} $$\nSolving for $m_{ss}$ yields the analytical expression for the steady-state abundance:\n$$ m_{ss} = \\frac{k_s}{d_0 + a\\,p} $$\nTo find the numerical value, we first compute the occupancy probability, $p$. The given concentrations are $[\\mathrm{miR\\text{-}21}] = 13\\,\\mathrm{nM}$ and $K_d = 7\\,\\mathrm{nM}$.\n$$ p = \\frac{[\\mathrm{miR\\text{-}21}]}{K_{d} + [\\mathrm{miR\\text{-}21}]} = \\frac{13\\,\\mathrm{nM}}{7\\,\\mathrm{nM} + 13\\,\\mathrm{nM}} = \\frac{13}{20} = 0.65 $$\nThe occupancy probability $p$ is a dimensionless quantity, as expected.\n\nNext, we calculate the total decay rate constant, $d_{total}$, using the given values $d_0 = 0.042\\,\\mathrm{min}^{-1}$ and $a = 0.055\\,\\mathrm{min}^{-1}$.\n$$ d_{total} = d_0 + a\\,p = 0.042\\,\\mathrm{min}^{-1} + (0.055\\,\\mathrm{min}^{-1})(0.65) $$\n$$ d_{total} = 0.042\\,\\mathrm{min}^{-1} + 0.03575\\,\\mathrm{min}^{-1} = 0.07775\\,\\mathrm{min}^{-1} $$\nFinally, we compute the steady-state mRNA abundance, $m_{ss}$, using the transcription rate $k_s = 8.4\\,\\text{molecules}\\cdot\\mathrm{min}^{-1}\\cdot\\mathrm{cell}^{-1}$.\n$$ m_{ss} = \\frac{k_s}{d_{total}} = \\frac{8.4\\,\\text{molecules}\\cdot\\mathrm{min}^{-1}\\cdot\\mathrm{cell}^{-1}}{0.07775\\,\\mathrm{min}^{-1}} $$\n$$ m_{ss} \\approx 108.038585... \\text{molecules}\\cdot\\mathrm{cell}^{-1} $$\nThe problem requires rounding the final numerical answer to four significant figures.\n$$ m_{ss} \\approx 108.0\\,\\text{molecules}\\cdot\\mathrm{cell}^{-1} $$\nThe units are consistent, as requested. The final result is the numerical value representing the number of mRNA molecules per cell at steady state.", "answer": "$$\\boxed{108.0}$$", "id": "4389740"}]}